72.27
+1.22
+(1.72%)
At close: 3:29:58 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,396,322.00
1,433,103.00
1,384,981.00
1,183,489.00
1,198,400.00
Cost of Revenue
1,129,384.00
1,185,963.00
1,127,275.00
957,266.00
989,800.00
Gross Profit
266,938.00
247,140.00
257,706.00
226,223.00
208,600.00
Operating Expense
170,489.00
146,839.00
188,712.00
173,132.00
153,000.00
Operating Income
96,449.00
100,301.00
68,994.00
53,091.00
55,600.00
Net Non Operating Interest Income Expense
-7,641.00
-7,298.00
-6,463.00
-5,919.00
-5,000.00
Pretax Income
106,154.00
113,349.00
100,989.00
64,830.00
37,000.00
Tax Provision
29,381.00
30,440.00
28,574.00
16,710.00
11,100.00
Net Income Common Stockholders
76,773.00
82,909.00
72,415.00
48,120.00
25,900.00
Diluted NI Available to Com Stockholders
76,773.00
82,909.00
72,415.00
48,120.00
25,900.00
Basic EPS
0.93
1.00
0.87
0.58
0.31
Diluted EPS
0.93
1.00
0.87
0.58
0.31
Basic Average Shares
82,578.39
82,984.00
82,984.00
82,984.00
82,984.00
Diluted Average Shares
82,578.39
82,984.00
82,984.00
82,984.00
82,984.00
Rent Expense Supplemental
--
--
734.00
315.00
--
Total Expenses
1,299,873.00
1,332,802.00
1,315,987.00
1,130,398.00
1,142,800.00
Net Income from Continuing & Discontinued Operation
76,773.00
82,909.00
72,415.00
48,120.00
25,900.00
Normalized Income
76,748.41
82,884.13
72,415.00
49,551.80
39,690.00
Interest Income
--
937.00
1,008.00
703.00
4,200.00
Interest Expense
6,768.00
6,425.00
5,804.00
5,067.00
7,900.00
Net Interest Income
-7,641.00
-7,298.00
-6,463.00
-5,919.00
-5,000.00
EBIT
112,922.00
119,774.00
106,793.00
69,897.00
44,900.00
EBITDA
171,296.00
177,362.00
161,203.00
92,081.00
61,400.00
Reconciled Cost of Revenue
1,129,384.00
1,185,963.00
1,127,275.00
957,266.00
989,800.00
Reconciled Depreciation
58,374.00
57,588.00
54,410.00
22,184.00
16,500.00
Net Income from Continuing Operation Net Minority Interest
76,773.00
82,909.00
72,415.00
48,120.00
25,900.00
Total Unusual Items Excluding Goodwill
34.00
34.00
--
-1,929.00
-19,700.00
Total Unusual Items
34.00
34.00
--
-1,929.00
-19,700.00
Normalized EBITDA
171,262.00
177,328.00
161,203.00
94,010.00
81,100.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
9.41
9.13
--
-497.20
-5,910.00
3/31/2021 - 2/8/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NECLIFE.BO Nectar Lifesciences Limited
39.35
+0.25%
BLISSGVS.BO Bliss GVS Pharma Limited
164.60
-0.66%
MEGASOFT.BO Megasoft Limited
80.63
-2.08%
NATCAPSUQ.BO Natural Capsules Limited
273.00
+0.89%
SOLARA.BO Solara Active Pharma Sciences Limited
678.80
+3.13%
STAR.BO Strides Pharma Science Limited
628.20
+8.00%
MEGASOFT.NS Megasoft Limited
81.46
-1.26%
SUNPHARMA.BO Sun Pharmaceutical Industries Limited
1,834.05
+2.01%
0867.HK CMS
7.010
-2.37%
GRANULES.NS Granules India Limited
599.60
+1.58%